Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jul;28(1):83–94. doi: 10.1111/j.1365-2125.1989.tb03509.x

Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.

A Martinsson 1, K Lindvall 1, A Melcher 1, P Hjemdahl 1
PMCID: PMC1379974  PMID: 2550046

Abstract

1. Different techniques of assessing beta-adrenoceptor sensitivity in vivo, by use of i.v. infusions or bolus injections of isoprenaline (ISO), were compared in healthy volunteers. The importance of autonomic reflexes for responses to ISO was evaluated by studying the influence of 'autonomic blockade' by atropine and clonidine, which antagonize muscarinic effects and reduce sympathetic activity, respectively. Estimates of in vivo responsiveness to ISO were compared with parameters reflecting beta 2-adrenoceptor function in vitro in lymphocytes. 2. Heart rate responses to infused ISO were not significantly altered by 'autonomic blockade' when evaluated from concentration-effect curves. When related to the infused dose of ISO, however, sensitivity was artefactually increased (P less than 0.05), as the plasma concentrations of ISO were 40% higher after atropine and clonidine. Heart rate responses to bolus injections of ISO were attenuated (P less than 0.05) by 'autonomic blockade', suggesting that facilitatory reflexes contribute to these non-steady state responses. Intersubject variations in heart rate responsiveness to ISO were greater than the intrasubject variability caused by counterregulatory reflexes. 3. 'Autonomic blockade' lowered venous plasma noradrenaline at rest. The noradrenaline response to ISO infusion was attenuated and the diastolic blood pressure response enhanced, indicating that a counterregulatory vasoconstrictor reflex normally is activated by ISO-induced vasodilatation. The plasma cyclic AMP response to ISO, on the other hand, was unaffected by atropine and clonidine and reflects beta 2-adrenoceptor responsiveness in vivo. 4. In vitro data for beta-adrenoceptor binding sites (Bmax;[125I]-IHYP binding) and cyclic AMP responses to ISO in lymphocytes correlated with DBP and noradrenaline responses to infused ISO. No correlations were found between in vitro data and heart rate, plasma cyclic AMP or plasma glycerol responses to infused ISO in vivo. 5. During prolonged ISO infusions (in six other healthy subjects) physiological responses reached greater than 90% of their steady state level after 8 min, but no definite steady state level could be defined for the plasma concentration of ISO during 40 min of infusion. 6. The ISO infusion test showed a good reproducibility, especially when repeated on the same day. Evaluation of plasma concentration-effect relationships increase the precision of the ISO infusion test as confounding inter- and intra-individual variations in ISO concentrations (as caused by e.g. autonomic blockade) will be taken into account.(ABSTRACT TRUNCATED AT 400 WORDS)

Full text

PDF
83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold J. M., McDevitt D. G. Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol. 1983 Apr;15(4):423–429. doi: 10.1111/j.1365-2125.1983.tb01525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold J. M., McDevitt D. G. Vagal activity is increased during intravenous isoprenaline infusion in man. Br J Clin Pharmacol. 1984 Sep;18(3):311–316. doi: 10.1111/j.1365-2125.1984.tb02469.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnold J. M., O'Connor P. C., Riddell J. G., Harron D. W., Shanks R. G., McDevitt D. G. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol. 1985 May;19(5):619–630. doi: 10.1111/j.1365-2125.1985.tb02689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brick I., Hutchison K. J., McDevitt D. G., Roddie I. C., Shanks R. G. Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol. 1968 Sep;34(1):127–140. doi: 10.1111/j.1476-5381.1968.tb07956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown B. L., Ekins R. P., Albano J. D. Saturation assay for cyclic AMP using endogenous binding protein. Adv Cyclic Nucleotide Res. 1972;2:25–40. [PubMed] [Google Scholar]
  6. Cleaveland C. R., Rangno R. E., Shand D. G. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med. 1972 Jul;130(1):47–52. doi: 10.1001/archinte.130.1.47. [DOI] [PubMed] [Google Scholar]
  7. Cryer P. E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980 Aug 21;303(8):436–444. doi: 10.1056/NEJM198008213030806. [DOI] [PubMed] [Google Scholar]
  8. Esler M., Jennings G., Leonard P., Sacharias N., Burke F., Johns J., Blombery P. Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl. 1984;527:11–16. [PubMed] [Google Scholar]
  9. Fitzgerald D., Doyle V., Kelly J. G., O'Malley K. Cardiac sensitivity to isoprenaline, lymphocyte beta-adrenoceptors and age. Clin Sci (Lond) 1984 Jun;66(6):697–699. doi: 10.1042/cs0660697. [DOI] [PubMed] [Google Scholar]
  10. Fredholm B. B., Lunell N. O., Persson B., Wager J. Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolites in diabetic and non-diabetic women. Diabetologia. 1978 Apr;14(4):235–242. doi: 10.1007/BF01219422. [DOI] [PubMed] [Google Scholar]
  11. George C. F., Conolly M. E., Fenyvesi T., Briant R., Dollery C. T. Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med. 1972 Sep;130(3):361–364. [PubMed] [Google Scholar]
  12. Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
  13. Hjemdahl P., Akerstedt T., Pollare T., Gillberg M. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl. 1983;515:45–53. [PubMed] [Google Scholar]
  14. Hjemdahl P. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 1987;142:521–534. doi: 10.1016/s0076-6879(87)42065-x. [DOI] [PubMed] [Google Scholar]
  15. Hjemdahl P., Daleskog M., Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979 Jul 9;25(2):131–138. doi: 10.1016/0024-3205(79)90384-9. [DOI] [PubMed] [Google Scholar]
  16. Hjemdahl P., Martinsson A., Larsson K. Improvement of the isoprenaline infusion test by plasma concentration measurements. Life Sci. 1986 Aug 18;39(7):629–635. doi: 10.1016/0024-3205(86)90044-5. [DOI] [PubMed] [Google Scholar]
  17. Jennings G., Bobik A., Esler M., Korner P. Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension. Clin Sci (Lond) 1981 Dec;61 (Suppl 7):177s–180s. doi: 10.1042/cs061177s. [DOI] [PubMed] [Google Scholar]
  18. Laurell S., Tibbling G. An enzymatic fluorometric micromethod for the determination of glycerol. Clin Chim Acta. 1966 Mar;13(3):317–322. doi: 10.1016/0009-8981(66)90210-5. [DOI] [PubMed] [Google Scholar]
  19. Martinsson A., Larsson K., Hjemdahl P. Reduced beta 2-adrenoceptor responsiveness in exercise-induced asthma. Chest. 1985 Oct;88(4):594–600. doi: 10.1378/chest.88.4.594. [DOI] [PubMed] [Google Scholar]
  20. Martinsson A., Larsson K., Hjemdahl P. Studies in vivo and in vitro of terbutaline-induced beta-adrenoceptor desensitization in healthy subjects. Clin Sci (Lond) 1987 Jan;72(1):47–54. doi: 10.1042/cs0720047. [DOI] [PubMed] [Google Scholar]
  21. Motulsky H. J., Insel P. A. Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations. N Engl J Med. 1982 Jul 1;307(1):18–29. doi: 10.1056/NEJM198207013070104. [DOI] [PubMed] [Google Scholar]
  22. Stiles G. L., Caron M. G., Lefkowitz R. J. Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev. 1984 Apr;64(2):661–743. doi: 10.1152/physrev.1984.64.2.661. [DOI] [PubMed] [Google Scholar]
  23. Sumner D. J., Elliott H. L. The pressor dose-response in clinical cardiovascular pharmacology. Br J Clin Pharmacol. 1987 May;23(5):499–503. doi: 10.1111/j.1365-2125.1987.tb03084.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sumner D. J., Elliott H. L., Vincent J., Reid J. L. A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man. Br J Clin Pharmacol. 1987 May;23(5):505–510. doi: 10.1111/j.1365-2125.1987.tb03085.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vestal R. E., Wood A. J., Shand D. G. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979 Aug;26(2):181–186. doi: 10.1002/cpt1979262181. [DOI] [PubMed] [Google Scholar]
  26. Vincent H. H., Man In't Veld A. J., Boomsma F., Wenting G. J., Schalekamp M. A. Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man. Br J Clin Pharmacol. 1982 May;13(5):717–721. doi: 10.1111/j.1365-2125.1982.tb01442.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES